Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP-144-SR (6M) vs (3M) in Prostate Cancer
NCT01546623Phase 3Completed
- Sponsor
- Takeda
- Start
- Mar 2012
- Primary completion
- Apr 2014
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of leuprolide in prostate cancer (PCa), sponsored by Takeda. Started Mar 2012; status: completed.
02
Drugs
leuprolide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01546623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01546623.